Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Proteostasis Therapeutics
Proteostasis Therapeutics
Tony Coles takes second neuroscience startup public as Yumanity reverse merges
Tony Coles takes second neuroscience startup public as Yumanity reverse merges
Endpoints
Tony Coles
Cerevel
Yumanity Therapeutics
cystic fibrosis
Proteostasis Therapeutics
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
FDA
Novartis
Ascendis
Eiger BioPharmaceuticals
Proteostasis Therapeutics
Fibrocell Science
Supernus Pharmaceuticals
FibroGen
INSYS Therapeutics
Flag link:
Genentech Licenses Non-CF Compound From Proteostasis in $100 Million-Plus Deal
Genentech Licenses Non-CF Compound From Proteostasis in $100 Million-Plus Deal
BioSpace
Genentech
Proteostasis Therapeutics
small molecule drugs
Flag link:
Proteostasis Therapeutics' Abrupt Turn-Around on Share Offering
Proteostasis Therapeutics' Abrupt Turn-Around on Share Offering
CP Wire
Proteostasis Therapeutics
stock offering
PTI-428
cystic fibrosis
clinical trials
Flag link:
Proteostasis Therapeutics' Abrupt Turn-Around on Share Offering
Proteostasis Therapeutics
Flag link:
